$924 Million is the total value of Slate Path Capital LP's 14 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 81.8% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PYPL | Buy | PAYPAL HLDGS INC | $171,045,000 | +1124.5% | 4,725,000 | +950.0% | 18.51% | +1055.2% |
CHTR | Sell | CHARTER COMMUNICATIONS INC Dcl a new | $126,339,000 | -3.1% | 690,000 | -7.0% | 13.67% | -8.6% |
TSO | Sell | TESORO CORP | $104,843,000 | -52.3% | 995,000 | -56.0% | 11.34% | -55.0% |
PODD | INSULET CORP | $102,843,000 | +45.9% | 2,720,000 | 0.0% | 11.13% | +37.7% | |
GDX | Sell | MARKET VECTORS ETF TRgold miner etf | $85,613,000 | -9.3% | 6,240,000 | -9.2% | 9.26% | -14.4% |
TRIP | New | TRIPADVISOR INC | $85,444,000 | – | 1,002,273 | +100.0% | 9.24% | – |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $68,252,000 | +42.7% | 725,000 | +21.8% | 7.38% | +34.7% |
Z | Buy | ZILLOW GROUP INCcl c cap stk | $56,000,000 | +100.4% | 2,385,000 | +130.4% | 6.06% | +89.0% |
TWC | Sell | TIME WARNER CABLE INC | $34,334,000 | -18.5% | 185,000 | -21.3% | 3.72% | -23.1% |
MDCO | New | MEDICINES CO | $21,284,000 | – | 570,000 | +100.0% | 2.30% | – |
OKE | New | ONEOK INC NEW | $19,851,000 | – | 805,000 | +100.0% | 2.15% | – |
WMB | New | WILLIAMS COS INC DEL | $16,962,000 | – | 660,000 | +100.0% | 1.84% | – |
CPGX | New | COLUMBIA PIPELINE GROUP INC | $16,100,000 | – | 805,000 | +100.0% | 1.74% | – |
KMI | New | KINDER MORGAN INC DEL | $15,368,000 | – | 1,030,000 | +100.0% | 1.66% | – |
IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -735,000 | -100.0% | -2.97% | – |
YOKU | Exit | YOUKU TUDOU INCsponsored adr | $0 | – | -3,690,000 | -100.0% | -7.46% | – |
SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -700,000 | -100.0% | -15.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
CHARTER COMMUNICATIONS INC N | 30 | Q3 2023 | 15.2% |
ALNYLAM PHARMACEUTICALS INC | 30 | Q3 2020 | 8.9% |
UNITED STATES STL CORP NEW | 24 | Q3 2023 | 11.4% |
NEW YORK TIMES CO | 23 | Q3 2023 | 10.9% |
VANECK VECTORS ETF TR | 21 | Q3 2023 | 19.5% |
PAN AMERN SILVER CORP | 21 | Q3 2023 | 7.6% |
CUE BIOPHARMA INC | 17 | Q3 2023 | 1.3% |
BARRICK GOLD CORPORATION | 16 | Q4 2020 | 15.7% |
MOSAIC CO NEW | 15 | Q4 2021 | 16.8% |
MEDICINES CO | 15 | Q4 2019 | 12.2% |
View Slate Path Capital LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Cue Biopharma, Inc. | February 14, 2023 | 2,402,455 | 5.6% |
Stitch Fix, Inc. | February 14, 2023 | ? | ? |
Cyclerion Therapeutics, Inc. | January 13, 2023 | 7,157,601 | 16.5% |
Zimmer Energy Transition Acquisition Corp. | February 14, 2022 | 2,000,000 | 5.8% |
5:01 Acquisition Corp. | February 11, 2022 | 500,000 | 5.8% |
Hippo Holdings Inc. | February 11, 2022 | 350,000 | 0.1% |
Warner Music Group Corp. | February 11, 2022 | 3,134,779 | 2.6% |
Reinvent Technology Partners Z | February 16, 2021 | 1,750,000 | 7.6% |
View Slate Path Capital LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G/A | 2024-01-22 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
SC 13G/A | 2023-02-14 |
SC 13G | 2023-02-14 |
13F-HR | 2023-02-14 |
SC 13G | 2023-01-13 |
SC 13G | 2022-11-18 |
View Slate Path Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.